Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial

Objective: This trial aimed to evaluate the glycemic control of polyethylene glycol loxenatide measured with continuous glucose monitoring (CGM) in patients with type 2 diabetes mellitus (T2DM), with the hypothesis that participants given PEG-Loxe would spend more time in time-in-range (TIR) than pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuo, Zhang, Chuanyan, Chen, Jingxian, Deng, Feiying, Wu, Zezhen, Zhu, Dan, Chen, Fengwu, Duan, Yale, Zhao, Yue, Hou, Kaijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194654/
https://www.ncbi.nlm.nih.gov/pubmed/37214446
http://dx.doi.org/10.3389/fphar.2023.1171399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194654/
https://www.ncbi.nlm.nih.gov/pubmed/37214446
http://dx.doi.org/10.3389/fphar.2023.1171399

Ejemplares similares